Roth began by sharing what he believes to be the single-most important characteristic of pharma company long-term survival ...
In today’s Pharma Pulse, the biopharma landscape enters a transformative phase as the US signs landmark PBM reforms into law, ...
The combination of GENEROUS for Medicaid, Globe for Medicare Part B and Guard for Medicare Part D will heavily impact the US drug market. President Trump’s rhetoric has been that other countries ...
By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to ...
In today’s Pharma Pulse, AstraZeneca faces a complete response letter for its self-injectable lupus drug, while the EMA gives ...
ORBIS Corporation's acquisition of Robinson Industries enhances manufacturing capabilities and accelerates production ...
In the final part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, outlines how real-time AI signal sharing across supply chain partners can help pharma ...
For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...
Körber, a provider of manufacturing and supply chain solutions—including for the pharma industry—has struck a deal to acquire ...
Hudicka also comments on practical steps can supply chain leaders take to build trust in AI-driven ecosystems without ...
In the first part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains how ...
Often referred to as AFPs, alternative funding programs are a third-party entity that works hand-in-hand with self-funded ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results